UNLV received a $3.2 million grant from the Alzheimer’s Drug Discovery Foundation to develop a biomarker observatory that will capture and categorize emerging information on blood tests, brain scans, and digital devices to help diagnose and monitor Alzheimer's disease and Parkinson's disease. This first-of-its-kind database will provide greater access to Alzheimer’s and Parkinson’s treatments to researchers around the world.